We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVEC icon
2426
NVE Corp
NVEC
$563M
$29.4K ﹤0.01%
394
– –
SLQT icon
2427
SelectQuote
SLQT
$126M
$29.3K ﹤0.01%
10,628
– –
AXGN icon
2428
Axogen
AXGN
$2.58B
$29.3K ﹤0.01%
4,047
– –
AMCX icon
2429
AMC Global Media
AMCX
$496M
$29.2K ﹤0.01%
3,026
– –
BALY icon
2430
Bally's
BALY
$660M
$29.2K ﹤0.01%
2,436
– –
IBD icon
2431
Inspire Corporate Bond ETF
IBD
$490M
$29.1K ﹤0.01%
1,249
-40
-3% -$932
TRML
2432
DELISTED
Tourmaline Bio
TRML
$29.1K ﹤0.01%
+2,262
New +$36.4K
BTBT icon
2433
Bit Digital
BTBT
$520M
$29K ﹤0.01%
9,122
– –
WEAV icon
2434
Weave Communications
WEAV
$426M
$29K ﹤0.01%
3,215
– –
RYAM icon
2435
Rayonier Advanced Materials
RYAM
$570M
$29K ﹤0.01%
5,330
– –
ADV icon
2436
Advantage Solutions
ADV
$423M
$29K ﹤0.01%
360
– –
AEHR icon
2437
Aehr Test Systems
AEHR
$4.02B
$28.7K ﹤0.01%
2,571
– –
SIGA icon
2438
SIGA Technologies
SIGA
$207M
$28.6K ﹤0.01%
3,774
– –
ORN icon
2439
Orion Group Holdings
ORN
$392M
$28.6K ﹤0.01%
+3,003
New +$26.5K
AGEN
2440
Agenus
AGEN
$315M
$28.5K ﹤0.01%
1,704
– –
MCS icon
2441
Marcus Corp
MCS
$929M
$28.5K ﹤0.01%
2,510
– –
RBBN icon
2442
Ribbon Communications
RBBN
$377M
$28.5K ﹤0.01%
8,663
– –
ENB icon
2443
Enbridge
ENB
$112B
$28.5K ﹤0.01%
800
– –
JRVR icon
2444
James River Group Holdings
JRVR
$200M
$28.4K ﹤0.01%
3,680
– –
NWPX icon
2445
NWPX Infrastructure Inc
NWPX
$1.11B
$28.4K ﹤0.01%
837
– –
ALEC icon
2446
Alector
ALEC
$228M
$28.4K ﹤0.01%
6,260
– –
EVLV icon
2447
Evolv Technologies
EVLV
$1.04B
$28.3K ﹤0.01%
11,113
– –
EMB icon
2448
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$28.3K ﹤0.01%
320
– –
GHM icon
2449
Graham Corp
GHM
$1.3B
$28.3K ﹤0.01%
+1,004
New +$28.9K
CRCT icon
2450
Cricut
CRCT
$1.24B
$28.3K ﹤0.01%
4,718
– –
96 97
98
99 100

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.